Vertex Pharmaceuticals (VRTX)
$211.58 1.50 (0.71%)
19:54 EDT VRTX Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 53.92B
PE Ratio 246.02
Volume (Avg. Vol.) 1.72M
Day's Range 209.07 - 213.51
52-Week Range 192.32 - 306.08
Dividend & Yield N/A (N/A)
VRTX Stock Predictions, Articles, and Vertex Pharmaceuticals News
- From InvestorPlace
- From the Web
Zoom Video, DraftKings, Vertex Pharma and GameStop were our top stock trades from Thursday. Here's a look at the charts.
Vertex Pharmaceuticals (VRTX) news for Thursday concerning bad results from one of its clinical trials is sending VRTX stock down.
The best Nasdaq stocks to buy aren’t those with the biggest capitalization gains, but those whose shares have put in the work on the price chart.
By Alex Sirois
Biotech stocks are futuristic, but they're also bearing fruit now. So, check out these five hitting on trends and making investors money now.
As investors begin to turn their attention away from Covid-19 and the novel coronavirus, these biotech stocks present excellent opportunities.
VRTX stock is a biopharmaceutical with an A-Rating that has no stake in the risky race for a coronavirus treatment.
Biotech stocks are in the spotlight in 2020, with the race to develop testing, treatment and a vaccine for Covid-19 driving rapid growth.
The long-term outlook is rosy for these five biotech stocks. They have the pipelines, partners and marketed drugs to provide years of growth for investors.
Growth is on a different track now, and here are some great ideas for stocks to buy to ride the momentum.
Investors looking for the safety of large-cap stocks alongside impressive growth should consider these five investments.
The stock charts of CAG, VRTX and HFC are poised to end the trading week in pivotal situations. Here's what you should know about each.
Here we take a closer look at five stocks with bullish calls from Goldman Sachs. As you will see, each of these stocks shows over 20% upside potential from current levels.
The stock charts of FTI, VRTX and STZ are knocking on the doors of major moves, even if the broad market isn't.
Biotech stocks have been looking rough lately, and these four names have been helping to lead the charge lower.
The stock charts of HollyFrontier, Activision Blizzard and Vertex Pharmaceuticals are poised to end the trading week in a pivotal situation.
Even in these unstable times, there are still gems to be found. And these are 10 of the hottest stocks on the Street, complete with "strong buy" analyst ratings and some compelling growth drivers.
Stock charts of VRTX, NKTR and SYMC are going to end the trading week knocking on the door of major moves.
Government is scrutinizing the drug development and approval process and creating uncertainties among biotech stocks. Time to buy?
From Talk Markets
Navellier RatingsPowered by Portfolio Grader